We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

GSK deal with generics may ‘abuse’ EU competition laws

Intellectual Property Magazine

GSK deal with generics may ‘abuse’ EU competition laws

Agreements between patent holders and generic manufactures to not enter a specific market may break EU competition law, a Court of Justice for the European Union (CJEU) advocate general has opined.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?


Request a trial Find out more